![](/img/cover-not-exists.png)
P2-274: Clinical benefits of pemetrexed 500 mg/m2 and 1000 mg/m2 in a randomized phase II study for pretreated patients with locally advanced or metastatic non–small cell lung cancer (NSCLC)
Kubota, Kaoru, Tamura, Tomohide, Yamamoto, Nobuyuki, Nakagawa, Kazuhiko, Morita, Satoshi, Nambu, Yoshihiro, Adachi, Susumu, Nishiwaki, Yutaka, Saijo, Nagahiro, Fukuoka, MasahiroVolume:
2
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1097/01.JTO.0000283982.22707.90
Date:
August, 2007
File:
PDF, 164 KB
english, 2007